NCT01162590View on ClinicalTrials.gov

Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 1, 2010

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Infections, Rotavirus
Interventions
BIOLOGICAL

Rotarix ™

Oral, single dose

BIOLOGICAL

Placebo

Oral, single dose

Trial Locations (1)

545200

GSK Investigational Site, Liucheng County

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY